| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-11 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.3 | 4e-10 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.29 | 4e-10 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-08 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.26 | 1e-07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.33 | 2e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.3 | 1e-06 |